Insud Pharma
Yolanda Sanchez has extensive experience in administrative support and management, currently serving as PMO & Executive Assistant to the Chief People & Corporate Affairs Officer at Insud Pharma since October 2018. Previously, roles included Executive Assistant to the Managing Director at Chemo, Personal Assistant to the Founder & President at Intropia, Ediciones del Prado, and Value Management and Research España S.A., where responsibilities encompassed office management, document preparation, and travel arrangements. Early career experience included positions at The Rockport Company and Advice Management - No More Discos, focusing on administrative support and office management. Yolanda Sanchez holds a Curso Superior Universitario en Técnicas de Secretariado de Dirección and a degree in Professional English, along with Microsoft Office Specialist certification in Excel 2016.
This person is not in the org chart
Insud Pharma
5 followers
INSUD PHARMA operates across the entire pharmaceutical value chain, delivering specialized expertise and experience in scientific research, development, manufacturing, sales and marketing of a wide range of value-adding active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and branded pharmaceuticals, for human and animal health. While the main offices are located in Madrid, Lugano, Buenos Aires, INSUD PHARMA is acting worldwide, creating a broad and balanced manufacturing and commercial network across Europe, America, Asia and Africa, to address global opportunities and customers` needs in all major pharmaceutical markets. INSUD PHARMA's activity is organized in three synergistic business areas: Industrial (Chemo), Branded (Exeltis) and Biotech (mAbxience), with over 7,300 professionals in more than 50 countries, 18 state-of-the-art facilities, 15 specialized R&D centers, 12 commercial offices and more than 35 pharmaceutical affiliates, serving 1,150 customers in 96 countries around the world. INSUD PHARMA believes in innovation and sustainable development. Our commitment is to improve people`s health and quality of life, providing access to quality medicines at affordable prices, and to continuously expand our efforts and R&D investment to develop new and better therapies.